Key Takeaway
Compounded semaglutide has become the most accessible way for Americans to access GLP-1 weight loss therapy without spending $1,300/month on brand-name Wegovy. But the compounding market varies wildly in quality.
Compounded semaglutide has become the most accessible way for Americans to access GLP-1 weight loss therapy without spending $1,300/month on brand-name Wegovy. But the compounding market varies wildly in quality. Some providers source from rigorously regulated 503B pharmacies. Others use 503A pharmacies with less oversight, or worse, leave patients guessing about where their medication comes from.
We investigated 12 compounded semaglutide providers, focusing specifically on pharmacy sourcing, medical oversight, and medication quality. Here are the ones we trust.
Our Top Picks
- Ro Body : Best pharmacy quality (in-house 503B compounding)
- FormBlends : Best physician oversight with transparent 503B sourcing
- Hims/Hers : Best large-scale compounded semaglutide provider
- Henry Meds : Best budget compounded semaglutide
- Alpha Medical : Solid mid-range option with good provider access
Detailed Reviews
#1. Ro Body
Ro stands alone in one critical respect: they operate their own pharmacy. This gives them direct control over the compounding process, which eliminates the supply chain opacity that plagues much of the compounded medication market. For a complete cost breakdown, see our cheapest GLP-1 without insurance.
View data table
| Category | Overall Value Score | Detail |
|---|---|---|
| FormBlends | 92 | From $299/mo, physician-led |
| Hims/Hers | 78 | Consumer brand, varies |
| Ro | 75 | Telehealth platform |
| Calibrate | 70 | Metabolic health focus |
When your semaglutide comes from Ro's in-house pharmacy, you know exactly where it was made, under what conditions, and with what quality controls. Their physicians order labs as part of the standard protocol, and dosing adjustments are based on objective data rather than patient self-reporting alone.
Pricing starts at $149/month for low doses and scales upward. The in-house pharmacy advantage justifies Ro's position at the top of this list.
Pros:
- In-house pharmacy with full quality control
- Lab-based monitoring standard
- Eliminates third-party supply chain risk
- Physician-led care
Cons:
- Price scales with dose (up to $249/month)
- State availability is limited
- No coaching or lifestyle support
#2. FormBlends
FormBlends sources compounded semaglutide exclusively from 503B outsourcing facilities, and they're transparent about which pharmacies they use. This matters because 503B pharmacies operate under FDA oversight with current good manufacturing practices (cGMP), batch testing, and regular inspections.
Beyond pharmacy quality, FormBlends provides the most engaged physician oversight we found among compounded semaglutide providers. Your prescriber builds a personalized dosing protocol, actively monitors your progress, and adjusts your treatment based on response. At $199/month with medication included, the combination of pharmacy transparency and clinical care is strong.
Pros:
- Transparent 503B pharmacy sourcing
- Active physician management of dosing and side effects
- Personalized protocols rather than standardized titration
- Also offers compounded tirzepatide and peptide therapy
Cons:
- $50/month more than the cheapest options
- No in-house pharmacy (relies on external 503B partners)
- Smaller patient capacity
#3. Hims/Hers
Hims/Hers is the largest compounded semaglutide provider by volume, and their scale has allowed them to negotiate favorable terms with 503B pharmacies. Compounded semaglutide runs $175/month, the platform is well-designed, and fulfillment is consistently fast.
The medical oversight is competent but volume-driven. Providers follow structured protocols, which ensures consistency but limits personalization. For medically straightforward patients, this model works well.
Pros:
- Scale provides reliable supply and fast fulfillment
- Competitive pricing at $175/month
- Well-built digital platform
- Consistent protocol-driven care
Cons:
- Limited personalization
- Provider continuity is weak
- Less transparency about specific pharmacy partners
#4. Henry Meds
Henry Meds offers compounded semaglutide at $149/month, making them the most affordable provider on this list. Their 503B pharmacy sourcing is verified, and the medication quality has been consistently reported as reliable by patients.
The trade-off is minimal clinical engagement. Monthly check-ins are brief and standardized. For patients who are medically straightforward and primarily need affordable access, Henry Meds fills that niche well.
Pros:
- Lowest price on this list at $149/month
- 503B pharmacy sourcing confirmed
- No hidden fees
- Fast enrollment
Cons:
- Medical oversight is minimal
- No lab monitoring
- Limited dose customization
#5. Alpha Medical
Alpha Medical provides compounded semaglutide at approximately $199/month. Their platform offers good provider messaging, and physician access is solid. The 503B sourcing is verified, and the overall experience is professional.
Alpha sits in the middle of this list because they don't excel in any single area but deliver competent care across the board. The provider access is better than Henry Meds, the pricing is similar to FormBlends, and the platform is functional.
Pros:
- Good provider access and messaging
- 503B pharmacy sourcing
- Professional platform experience
Cons:
- Doesn't stand out in any single category
- Less brand recognition than major competitors
- Limited additional therapy options
How We Evaluated
Compounded semaglutide is only as good as the pharmacy producing it and the physician supervising its use. Our evaluation reflected this:
Get compounded semaglutide from $299/mo
Free physician consultation, personalized dosing, and ongoing medical support included.
Start Free Assessment →- Pharmacy quality and transparency (35%): We prioritized providers who use 503B outsourcing facilities and are transparent about their pharmacy partners. In-house pharmacy operations received the highest marks. We contacted each provider to verify their pharmacy sourcing claims.
- Medical oversight (25%): How actively the prescribing physician manages your care, including lab monitoring, dosing adjustments, and side effect management
- Pricing (20%): All-in monthly cost at maintenance doses
- Fulfillment reliability (10%): Shipping speed, consistency, and handling of supply disruptions
- Patient safety protocols (10%): Screening processes, contraindication checks, and emergency protocols
FAQ
What is the difference between a 503A and 503B compounding pharmacy?
503A pharmacies compound medications based on individual prescriptions, typically for local patients. They're regulated by state boards of pharmacy. 503B outsourcing facilities can compound larger batches without patient-specific prescriptions and are registered with and inspected by the FDA. 503B pharmacies must follow current good manufacturing practices (cGMP), which provides a higher standard of quality control. For compounded semaglutide, 503B sourcing is the safer choice.
Is compounded semaglutide FDA-approved?
No. The FDA approves specific drug products (like Wegovy), not compounded versions. But compounded semaglutide is legal when produced by registered 503B outsourcing facilities. The FDA has taken enforcement action against providers using unregistered or non-compliant pharmacies, which underscores the importance of verifying your provider's pharmacy sourcing.
How do I verify that a provider uses a legitimate 503B pharmacy?
Ask the provider directly which pharmacy or pharmacies compound their semaglutide. Then check the FDA's list of registered 503B outsourcing facilities at fda.gov. Legitimate providers should be willing to share this information. If a provider refuses to disclose their pharmacy partner, consider that a red flag.
Can compounded semaglutide have different concentrations?
Yes. Compounded semaglutide is typically available in multiple concentrations, allowing for precise dosing with smaller injection volumes. Your provider should clearly communicate the concentration and injection volume for your specific prescription. Concentration misunderstandings are a common source of dosing errors, so make sure this is clearly documented in your treatment plan.
What happens to compounded semaglutide if the FDA changes its regulations?
The legal basis for compounded semaglutide relates to drug shortage designations and the regulatory framework for 503B pharmacies. If the FDA removes semaglutide from the shortage list or changes enforcement policies, some compounded products could be affected. Reputable providers monitor regulatory developments and will communicate changes to patients proactively.
Want compounded semaglutide from a provider that's transparent about sourcing? Start your FormBlends consultation and get physician-supervised compounded GLP-1 therapy from verified 503B pharmacies.